Global Hemostasis And Tissue Sealing Agents Market Analysis & Forecast 2024-2034: Significant Growth by 2034 Amid Technological Advancements and Increasing Surgical Procedures [Yahoo! Fina...
Artivion, Inc. (AORT)
Company Research
Source: Yahoo! Finance
Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. The global demand for hemostasis and tissue sealing agents is witnessing unprecedented growth, with a forecast projecting the market to amplify from USD 8.04 billion in 2023 to an impressive USD 20.71 billion by 2034, at a CAGR of 8.98% during the period from 2024 to 2034. This notable expansion is attributed to a suite of factors including a rise in surgical interventions, an aging population, and the escalating incidence of chronic diseases. Technological Innovations Propel Market Developments A surge in the introduction of advanced tissue sealing devices is set to significantly propel market growth throughout the forecast period. Adopting hemostats and sealants, which provide a means to cease bleeding and manage hemorrhaging from injuries and surgeries, is increasingly favored over traditional wound closure methods, particularly in endoscopic procedures. Product Advancements
Show less
Read more
Impact Snapshot
Event Time:
AORT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AORT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AORT alerts
High impacting Artivion, Inc. news events
Weekly update
A roundup of the hottest topics
AORT
News
- Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial ResultsPR Newswire
- Artivion's (NYSE:AORT) investors will be pleased with their notable 43% return over the last year [Yahoo! Finance]Yahoo! Finance
- Is Artivion (AORT) Outperforming Other Medical Stocks This Year? [Yahoo! Finance]Yahoo! Finance
- Artivion, Inc. (NYSE: AORT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $25.00 price target on the stock.MarketBeat
- ENSEMBLE ORTHOPEDICS ANNOUNCES 700TH IMPLANTATION OF ITS MINIMALLY-INVASIVE PYROCARBON INTERPOSITIONAL CMC [Yahoo! Finance]Yahoo! Finance
AORT
Earnings
- 2/15/24 - Beat
AORT
Sec Filings
- 4/1/24 - Form ARS
- 4/1/24 - Form DEFA14A
- 4/1/24 - Form DEF
- AORT's page on the SEC website